These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9269240)

  • 1. Growth hormone in end-stage heart failure.
    Dreifuss PM
    Lancet; 1997 Jun; 349(9068):1841-2; author reply 1843. PubMed ID: 9269240
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth hormone in end-stage heart failure.
    Khardori R; Taraben A; Taylor GJ; Falcone M
    Lancet; 1997 Jun; 349(9068):1842; author reply 1843. PubMed ID: 9269241
    [No Abstract]   [Full Text] [Related]  

  • 3. Growth hormone therapy as a treatment for heart failure.
    McKelvie RS
    Evid Based Cardiovasc Med; 2006 Jun; 10(2):81-4. PubMed ID: 16753500
    [No Abstract]   [Full Text] [Related]  

  • 4. GH and cardiac failure.
    Cuneo RC
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4635-7. PubMed ID: 11600517
    [No Abstract]   [Full Text] [Related]  

  • 5. The potential for growth hormone in the management of heart failure.
    Monson JP; Besser GM
    Heart; 1997 Jan; 77(1):1-2. PubMed ID: 9038681
    [No Abstract]   [Full Text] [Related]  

  • 6. Growth hormone in end-stage heart failure.
    Wilmshurst P
    Lancet; 1997 Jun; 349(9068):1842-3. PubMed ID: 9269242
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of somatotropin in treating chronic circulatory failure].
    Bondarenko IP; Dubinskiĭ AA
    Vrach Delo; 1982 Jan; (1):41-5. PubMed ID: 7072211
    [No Abstract]   [Full Text] [Related]  

  • 8. Growth hormone and testosterone in heart failure therapy.
    Agarwal M; Naghi J; Philip K; Phan A; Willix RD; Schwarz ER
    Expert Opin Pharmacother; 2010 Aug; 11(11):1835-44. PubMed ID: 20486829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac performance: growth hormone enters the race.
    Saccà L; Fazio S
    Nat Med; 1996 Jan; 2(1):29-31. PubMed ID: 8564831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone in the treatment of heart failure: a new tool for the future?
    Jonkman FA; De Jong G; Fioretti PM
    Eur Heart J; 1997 Feb; 18(2):181-4. PubMed ID: 9043830
    [No Abstract]   [Full Text] [Related]  

  • 11. Growth hormone as a potential future therapy for congestive heart failure.
    Fazio S; Cittadini A; Biondi B; Palmieri EA; Saccà L
    Coron Artery Dis; 1999 Sep; 10(6):383-8. PubMed ID: 10474788
    [No Abstract]   [Full Text] [Related]  

  • 12. Growth hormone therapy for heart failure: swimming against the stream.
    Saccà L
    J Card Fail; 1999 Sep; 5(3):269-75. PubMed ID: 10496200
    [No Abstract]   [Full Text] [Related]  

  • 13. Growth hormone and proinflammatory cytokine activation in heart failure. Just a new verse to an old sirens' song?
    Wollert KC; Drexler H
    Eur Heart J; 2003 Dec; 24(24):2164-5. PubMed ID: 14659767
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of somatotropin on chronic circulatory insufficiency].
    Bondarenko IP
    Ter Arkh; 1982; 54(5):126-8. PubMed ID: 7101174
    [No Abstract]   [Full Text] [Related]  

  • 15. Myths and truths of growth hormone and testosterone therapy in heart failure.
    Nguyen CT; Aaronson A; Morrissey RP; Agarwal M; Willix RD; Schwarz ER
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):711-20. PubMed ID: 21714602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anabolic agents in the therapy of chronic circulatory failure].
    Bondarenko IP
    Vrach Delo; 1982 Sep; (9):52-5. PubMed ID: 6758353
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy.
    Osterziel KJ; Strohm O; Schuler J; Friedrich M; Hänlein D; Willenbrock R; Anker SD; Poole-Wilson PA; Ranke MB; Dietz R
    Lancet; 1998 Apr; 351(9111):1233-7. PubMed ID: 9643742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of the GH/IGF-1 axis in cardiovascular physiopathology and therapy: the lessons from animal studies].
    Cittadini A; Durante Mangoni E; Palmieri EA; Casaburi C; Longobardi S; Di Rella F; Fazio S; Saccà L
    Cardiologia; 1998 Nov; 43(11):1185-92. PubMed ID: 9922584
    [No Abstract]   [Full Text] [Related]  

  • 19. [Growth hormone--new therapy in heart failure?].
    Ben-Gal T; Adler Y; Battler A
    Harefuah; 2000 Jun; 138(12):1070-4. PubMed ID: 10979437
    [No Abstract]   [Full Text] [Related]  

  • 20. Beneficial effects of high doses of growth hormone in the introduction and optimization of medical treatment in decompensated congestive heart failure.
    Bocchi E; Moura L; Guimarães G; Conceição Souza GE; Ramires JA
    Int J Cardiol; 2006 Jun; 110(3):313-7. PubMed ID: 16099518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.